micro-community-banner
 
  • Saved

Mean HF score was higher in the worsening HF hospitalization (WHFH) group than in the no WHFH group, even at the beginning of 12 weeks.

  • Saved
Emerging Biomarkers in the Laboratory and in Practice: a Novel Approach to Diagnosing Heart Failure in Diabetes

Emerging Biomarkers in the Laboratory and in Practice: a Novel Approach to Diagnosing Heart Failure in Diabetes

Source : https://pubmed.ncbi.nlm.nih.gov/38292004/

The Biomarkers for the Diagnosis of Heart Failure in Diabetes webinar was hosted by Diabetes Technology Society on September 20, 2023, with the objective to review current evidence and management...

Experts in HF from clinical chemistry, cardiology, and diabetology present data on screening for HF as an often-unnoticed complication of people with type 1 and type 2 diabetes.

  • Saved
Clinical Characteristics and Outcome of End Stage Hypertrophic Cardiomyopathy: Role of Age and Heart Failure Phenotypes

Clinical Characteristics and Outcome of End Stage Hypertrophic Cardiomyopathy: Role of Age and Heart Failure Phenotypes

Source : https://pubmed.ncbi.nlm.nih.gov/38242504/

Two different HCM-ES phenotypes can be recognized, with ES-pEF showing distinctive features at ES recognition and receiving less frequently advanced HF treatments. Older age at ES recognition has a major...

Two different end-stage HCM phenotypes can be recognized, with end-stage pEF showing distinctive features at end-stage recognition and receiving less frequently advanced HF treatments.

  • Saved

Among patients with HFimpEF, treatment with dapagliflozin was associated with lower rates of cardiovascular death relative to placebo, a difference primarily due to lower rates of sudden death.

  • Saved
Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure

Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure

Source : https://pubmed.ncbi.nlm.nih.gov/38231622/

Among patients with a reduced ejection fraction, a widened QRS complex, and NYHA class II or III heart failure, the survival benefit associated with receipt of a CRT-D as compared...

Among patients with a reduced ejection fraction, a widened QRS complex, and NYHA class 2/3 heart failure, the survival benefit associated with receipt of a cardiac-resynchronization therapy defibrillator as compared with implantable cardioverter-defibrillators appeared to be sustained during a median of nearly 14 years of follow-up.